Telomerase Revolution with Dr. Michael Fossel

 In Alzheimer's Disease, Cancer, Dementia, Genetics, Health

Telomerase Revolution  » Listen Now

Date: February 20, 2017

Episode Description for Telomerase Revolution

When thinking of getting older, most people feel it’s an overwhelming and unavoidable journey to feeling unwell and living with pain.  What if that wasn’t true?  What if we were able to slow down the aging process and avoid age related disease?  Dr. Michael Fossel has been involved in Telomerase science for years.   Today we’re discussing his latest book, The Telomerase Revolution, which was praised by the Wall Street Journal as one of the five best science books of the year.

 Dr. Risk’s Thoughts

I found this book fascinating.  When I first read about Telomerase, it seemed to be revolutionary.  We are always searching for what it is that makes us age, and I feel that this will become part of it once we have a better understanding.  Although I think we are still looking for the fountain of youth, this might be the right road.

Guest Information

Michael Fossel

Dr. Fossel has an MD and a PhD (in neurobiology) from Stanford University. A clinical professor of medicine for almost 3 decades, he is considered the world foremost expert on telomeres, aging, and age-related disease. He published the very first articles on the potential of telomeres as a clinical intervention two decades ago, and is the author of the only medical textbook in this field, Cells, Aging, and Human Disease. He was the editor-in-chief of several medical journals, the director of the American Aging Association, and is the current medical advisor of the Dementia Society of America. He has authored multiple books, chapters, and articles, including his latest book, The Telomerase Revolution, which was praised by the Wall Street Journal as one of the five best science books of the year. He is founder and president Telocyte, a biotech firm taking telomere therapy to human trials next year to cure Alzheimer’s.

Recommended Posts
Contact Us

We're not around right now. But you can send us an email and we'll get back to you, asap.

Not readable? Change text.